Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,973.00
Bid: 1,971.00
Ask: 1,973.00
Change: -3.00 (-0.15%)
Spread: 2.00 (0.101%)
Open: 1,968.00
High: 1,976.00
Low: 1,946.00
Prev. Close: 1,973.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Energy, healthcare stocks lift FTSE 100; BHP Group shines

Tue, 17th Aug 2021 09:46

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* UK employment closer to pre-pandemic levels

* BHP Group jumps on strong results

* PLUS500 gains on robust revenue forecasts

* FTSE 100 up 0.3%, FTSE 250 off 0.2%
(Updates to close)

By Shashank Nayar and Amal S

Aug 17 (Reuters) - London's FTSE 100 rose on Tuesday, helped
by gains in heavyweight energy and healthcare stocks, with
sentiment bolstered by robust earnings from BHP Group and
employment numbers that showed a steady economic recovery in the
UK.

After falling as much as 0.5%, the blue-chip FTSE 100 index
ended 0.3% higher, helped by oil majors BP and
Royal Dutch Shell as crude prices recouped early
losses.

Healthcare stocks rose 1.1% with drugmakers
including AstraZeneca, GlaxoSmithKline, and
Hikma Pharmaceuticals rising between 1% and 2.3%.

Miner BHP Group gained 3.1% to the top of the FTSE
100 after posting its best annual profit in nearly a decade. It
also announced an exit from its $13 billion petroleum business
in a portfolio shake-up that will see it leave London's FTSE 100
index.

"BHP has a clear strategy now of focusing on future-proofed
commodities which are part of the transition away from fossil
fuels or in other words being part of the solution rather than
part of the problem and it's an approach which is winning favour
from the market," said Russ Mould, investment director at AJ
Bell.

Steadily rising commodity prices and cheap interest rates
have helped the FTSE 100 rise nearly 11% year-to-date, but
inflation pressure, risks linked to the coronavirus pandemic and
less weightage of tech stocks on the index have led it to
underperform developed-market peers.

The number of employees on British company payrolls rose by
182,000 in July from June, moving closer to their pre-pandemic
level as the economy recovers from its coronavirus lockdowns,
tax data showed.

Unemployment in the UK dropped to 4.7% in the three months
to June, lower than economist expectations of 4.8%.

The domestically focussed mid-cap index eased 0.2%,
with travel stocks declining the most.

Online trading platform Plus500 jumped 5.1% to the
top of the mid-cap index after it forecast annual revenue
"significantly ahead" of analysts' estimates.

UK-listed shares of food-ordering firm Just Eat Takeaway.com
gained 2.9% and was the second-best performer on FTSE
100, after it reported a better-than-expected operating loss of
190 million euros ($224 million) for the first half of
2021.
(Reporting by Shashank Nayar and Amal S in Bengaluru; Editing
by Subhranshu Sahu and Uttaresh.V and Bernadette Baum)

More News
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
27 Sep 2021 12:14

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.